Don’t hold your breath wait­ing for FDA nom­i­nee; A pri­or­i­ty re­view for an­oth­er Bris­tol My­ers part­ner

If you’re one of the thou­sands of biotech ex­ec­u­tives, con­sul­tants, ac­tivists, sci­en­tists, jour­nal­ists or just a gen­er­al watch­er wait­ing to see who Pres­i­dent Biden will nom­i­nate to lead the FDA, don’t hold your breath.

HHS Sec­re­tary Xavier Be­cer­ra told Bloomberg Law Wednes­day that Biden will make the nom­i­na­tion once the busy pres­i­dent finds time to make the de­ci­sion.

“This is one of those po­si­tions where ob­vi­ous­ly the pres­i­dent is very in­ter­est­ed be­cause FDA is just not an­oth­er agency, it’s a crit­i­cal agency,” Be­cer­ra said. “They’ve done some tremen­dous things dur­ing Covid. So I think what you’re go­ing to do is find that as soon as the pres­i­dent has a chance to think a lit­tle bit clos­er, we’ll be able to work with him to see if we can get a nom­i­nee.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.